OlgaSelioutskiDOFACNS, FAES, FACN(She/Her)

Epilepsy, Neurophysiology

Professor of Neurology, University of Mississippi and Adjunct Faculty at the University of Rochester School of Medicine & Dentistry; Vice Chair AAN Epilepsy Section; Chair-Elect ACNS Guidelines Committee

Join to view full profile

Dr. Selioutski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Selioutski's full profile

Already have an account?

Office
181 N Belle Mead Rd
East Setauket, NY 11733
Phone+1 631-444-2599

Summary

Dr. Olga Selioutski is a neurologist in Jackson, MS. She is a Professor of Neurology and Epilepsy Division Chief at the University of Mississippi Medical Center. She received her medical degree from Lake Erie College of Osteopathic Medicine - Seton Hill and has been in practice for over 15 years. She also speaks multiple languages, including Russian. She specializes in epilepsy and neurophysiology and is experienced in general neurology, epilepsy, and clinical neurophysiology. She has more than 40 publications.

Olga Selioutski, D.O. - University of Mississippi

https://www.umc.edu/Provider/Selioutski_Olga/

Education & Training

Lake Erie College of Osteopathic Medicine - Seton HillClass of 2002

Certifications & Licensure

MS State License 2022 - 2025
NY State License 2006 - 2025
PA State License 2002 - 2012
AOA Board of Neurology and Psychiatry Neurology

Awards, Honors, & Recognition

Fellow ACNS
Fellow AES, 2018
Fellow ACN, 2018
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Join now to see all

Clinical Trials

Eslicarbazepine Acetate Monotherapy Long Term Study Start of enrollment: 2009 Aug 01
Completed
Phase 3
Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures Start of enrollment: 2008 Dec 02
Completed
Phase 3
Safety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current Antiepileptic Start of enrollment: 2010 Jun 01
Completed
Phase 3
Study to Evaluate the Safety and Efficacy of USL261 in Patients With Increased Bouts of Seizure Activity in the EMU Start of enrollment: 2013 Nov 01
Completed
Phase 3
Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus Start of enrollment: 2014 Mar 21
Completed
Phase 1, Phase 2
An Open Label, Expanded Access Protocol With SAGE-547 for Super-Refractory Status Epilepticus
No longer available
A Study With SAGE-547 for Super-Refractory Status Epilepticus Start of enrollment: 2015 Jun 01
Completed
Phase 3
A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting Start of enrollment: 2017 Feb 06
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
Correlations Between Quantitative EEG Parameters and Cortical Blood Flow in Patients Undergoing Extracorporeal Membrane Oxygenation With and Without Encephalopathy.
Imad R Khan, Irfaan A Dar, Thomas W Johnson, Emily Loose, Yama Y Xu
Journal of Clinical Neurophysiology. 2024-11-01
Lack of Continuous Video EEG Surveillance Results in Delayed Event Reporting.
Olga Selioutski, Peggy Auinger, Michel Berg, Ramona Cranmer, Gretchen L Birbeck
The Neurodiagnostic Journal. 2024-09-01
Patient Handoff Practices at the Epilepsy Centers in the United States: A Survey of the Medical Directors.
Olga Selioutski, Susan Herman, Eva Katharina Ritzl, Matthew Garlinghouse, Olga Taraschenko
Journal of Clinical Neurophysiology. 2024-06-25

Abstracts/Posters

GCS Predicts Survival and Discharge Disposition in Patients with Acute Cerebral Injury
Hamilton, R; Ghosh, H; Nickels, J; Konig-Toro, F; Kruppenbacher, M; Roberts, D; Kaplan, P; Birbeck, G; Selioutski, O., AAN, 2018
Common Exclusionary Criteria Eliminate Two-Thirds of EMU Patients from Study Participation
Connolly, N; M. Berg, M; Selioutski, O, AES, 2018
Evaluation of serum Phenytoin levels 24 hours following a single intravenous loading dose
Selioutski, O; Liu, L; Hilmarsson, A; Bonno, D; Fessler, A; Gross, R., AES, 2015
Clinical Presentation, Treatment and Outcomes in Autoimmune Encephalitis at URMC: What is Really Important?
Smith, A; Samkoff, L; Selioutski, O., URMC Steven R. Schwid Neurology/Neurosurgery Resident, Fellow and Student Research Symposium, UR, Rochester, NY, 2015
Intraoperative Neurophysiological Monitoring In Spine Surgery
Okafor, R; Molinari, W; Selioutski, O; Gannon, S; Mesfin, A., American Orthopedic Society Meeting, 2015
The utility of outpatient EEGs in diagnosing paroxysmal events in the elderly
16. Selioutski, O; Liu, L., Epilepsia. 2007; 48(S6):27, 2007
Join now to see all

Authored Content

Medical Myelopathies. Rothman-Simeone and Herkowitz's The Spine, 2 Vol Set, 7th EditionNovember 2017
Can a VBAC scoring system predict uterine rupture in patients attempting a trial of labor?April 1999